Ipsen Archives - Pharmaphorum

Ipsen launches new syringe for rare disease blockbuster

https://pharmaphorum.com/news/ipsen-launches-new-syringe-for-rare-disease-blockbuster/

Ipsen to buy rare disease firm Clementia for up to $1.31bn

https://pharmaphorum.com/news/ipsen-to-buy-rare-disease-firm-clementia-for-up-to-1-31bn/

Chinese patients to get new drugs before UK after Brexit – says CEO

https://pharmaphorum.com/news/chinese-patients-new-drugs-before-uk-brexit-ceo/

Ipsen warns over medicine supplies amid Brexit uncertainty

https://pharmaphorum.com/news/ipsen-warns-over-medicine-supplies-amid-brexit-uncertainty/

EU approves Ipsen’s Cabometyx in second line liver cancer

https://pharmaphorum.com/news/european-commission-cabometyx/

EU regulators back Ipsen cancer drug in new liver cancer use

https://pharmaphorum.com/news/eu-regulators-cabometyx-liver/

Ipsen appoints new general manager for the UK & Ireland

https://pharmaphorum.com/news/ipsen-appoints-new-general-manager/

Scotland’s NHS to fund Ipsen cancer diarrhoea drug

https://pharmaphorum.com/news/scotlands-nhs-ipsen-cancer-drug/

EU approves Ipsen’s Cabometyx in first line kidney cancer

https://pharmaphorum.com/news/eu-approves-ipsens-cabometyx-in-first-line-kidney-cancer/

Search